Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RE-AHFIRM (RandomizEd Study of Larsucosterol in Alcohol-associated Hepatitis to Confirm saFety and effIcacy of tReatMent)

NCT07428538 is registered in ClinicalTrials.gov with Bausch Health Americas, Inc. as lead sponsor.

NCT NCT07428538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07428538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RE-AHFIRM (RandomizEd Study of Larsucosterol in Alcohol-associated Hepatitis to Confirm saFety and effIcacy of tReatMent)
Lead sponsor
Bausch Health Americas, Inc.
Phase
Phase 3
Overall status
Recruiting
Start date
January 29, 2026
Completion date
February 29, 2028
Enrollment
350 (estimated)
Sites
92

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis